Current Size: 100%

Ludwig Boltzmann Institute for COPD And Respiratory Epidemiology

"Low SARS-CoV-2 seroprevalence in the Austrian capital after an early governmental lockdown" has been published!

NEW! The results of our LEAD-COVID antibody study have been published in Scientific Reports.

Research saves lives

The Austrian LEAD Study is the world’s biggest study on COPD and examines the Austrian lung health with a long-term and holistic approach. We want to thank all our supporters and sponsors, without whose help the conduction of the study would be impossible. For the continued existence of the study, we also need your support!